India has reacted to this after the US has announced a tariff of up to 100% on branded and patented medicines from October 1. Foreign Ministry spokesman Randhir Jaiswal said that it has been closely monitored. Jaiswal told in the press briefing that India is constantly monitoring the matter.
Jaiswal said that after receiving notices related to the new tariff on social media, India has seen reports on pharma and other related products. He informed that the concerned ministries and departments are closely monitoring the matter and are studying its possible impact.
India gives most generic medicines to America
India is the world’s largest supplier of generic drugs and exports more than one-third of drugs consumed in the US. These drugs are not under patent and are cheaper than branded editions. Trump’s 100% tariff focuses on branded drugs, but industry experts say that the absence of generic drugs in Trump’s order does not eliminate the risk for India.
Trump announced on social media
The US President wrote on social media platform Truth Social, ‘From 1 October 2025 we will impose 100 percent tariffs on any branded or patent pharmaceutical products, until the company is building its pharmaceutical manufacturing plant in the US.’
Trump put new tariffs on separate imports
In his recent tariff decision, Trump has imposed 50% tariffs on kitchen cabinet and bathroom vanities, 30% on chairs and couchs and 25% on heavy trucks. Although Trump did not give any legal reason for these tariffs, he said that these taxes are necessary for “national security and other reasons”, which challenged the limits of role as his commander-in-chief.